Cite

    Luis Rivera et al.. “Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.” Lancet infectious diseases, vol. 17, no. 7, n.d., pp. 745–753. http://access.bl.uk/ark:/81055/vdc_100047027155.0x00001a